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Dear Editor,
We are in amidst of a pandemic. While writing this letter, COVID-
19, which is a devastating pandemic on humankind, has already 
infected 6,311,980 all over the world and has led to the death 
of 374,847 people in our planet. Till now, there is no cure for 
this dreadful disease, but many vaccines are on pipeline, which 
need months for clinical trials. Even though COVID-19 has only a 
mortality rate around 3%, and most of the patients are cured with 
minimal symptoms, the recurrence of the disease is questionable.[1] 
In spite of our knowledge in viral immunity, it has been shown that 
certain patients are reinfected. A report from Germany showed 
that a patient who was found to be resolved from the disease 
infected two other people. These new patients were discovered by 
contact tracing.[2]
There can be many reasons for this. First, do these viruses 
evade immunity, which necessitates the need of studies on newer 
aspects of viral immunity? Second, are these viruses shed in feces 
and whether they continued to be transmitted is another question 
of debate? Viral shedding from the digestive system might be more 
severe and lasting longer than that from the respiratory tract.[3] 
Third, there is the question of viral mutation. It has been reported 
that SARS-CoV-2 mutated some portion of its genome.[4] That can 
be the answer to repeated infection unlike usual flu viruses.
Finally, the time taken for viral clearance also has to be taken 
into account after all the symptoms are resolved. Studies from 
China showed that patients with COVID-19 after the resolution 
of symptoms were positive for SARS-CoV-2.[5] At present, there 
is no evidence that people who have recovered from COVID-19 
and have antibodies are protected from a second infection. A 
study in which neutralizing antibody was considered says titers of 
neutralizing antibody that was not high in about 30% of patients. 
Moreover, the same study reports about low neutralizing antibody 
in recovered patients, while it reported elderly patients producing 
higher titers of antibody compared to younger patients, which is 
related to the severity of the disease.[6] This is also evident in non-
human primates.[7] The reinfection of coronavirus is controversial 
as a study on rhesus monkeys showed that reinfection could not 
occur in SARS-CoV-2-infected rhesus macaques.[8]
The case report of a 46-year-old woman showed that the 
patient was positive for SARS-CoV-2 using reverse transcription-
polymerase chain reaction (RT-PCR) method when the specimen 
used was oropharyngeal swab (can be reframed). Later, the patient 
underwent serials of RT-PCR testing which came as negative. The 
patient test results again became positive after these serial negative 
tests.[9] Authors speculated that currently, many researchers are 
not in a consensus regarding the contagious period of COVID-19. 
Hence, they consider a person in a convalescence period, which 
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may also be infectious. They then extended their view regarding 
the possibility of false-negative results from upper respiratory tract 
specimen. This is because angiotensin-converting enzyme-2 which 
is supposed to be the cell entry receptor of SARS-CoV-2 is highly 
expressed in lungs rather than in the upper respiratory tract.[10]
It has been shown that some patients after getting discharged 
from the hospital found to be showing symptoms like fever and 
were positive for nucleic acid test. There can be many reasons for 
this, but some authors point this to reinfection of the virus.[11]
A case in which a woman of 56 years was confirmed as COVID-
19 using laboratory investigations and turned into negative after 
doing twice nucleic acid testing with an interval of 24 h. But later, 
she was turned to be positive again after doing nucleic acid testing.
However, on the other hand, some authors say even though 
14% of the discharged patients tested virus-positive again, it is 
unlikely to be reinfection rather may be derived from the remained 
virus transferred from the lower respiratory tract to the throat or 
nose with coughs.
However, some authors suggested that since existing data 
are limited data regarding antibody responses to SARS-CoV-2; 
then, recovery from COVID-19 might result in immunity against 
reinfection, at least temporarily.
However, health authorities are to be aware of the above said 
concerns because such patients may be at risk of complication, 
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rebound infection, and also in spreading COVID-19 to their 
contacts.
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